Progress of research on the role of amino acid metabolism disturbance in the transition from AKI to CKD

doi:10.3877/cma.j.issn.2095-3216.2024.05.008

Abstract

Abstract:

Acute kidney injury （AKI） is characterized by rapid deterioration of kidney function，whose remnant renal injury may progressively lead to chronic kidney disease （CKD） even after the complete recovery of kidney function. At present，the mechanism of transition from AKI to CKD has not been fully understood，in which AKI-related abnormalities of amino acid metabolism may play an important role in the transition from AKI to CKD. This article reviewed the research progress on the role of abnormalities in amino acid metabolism in the transition from AKI to CKD，aiming to provide new ideas for preventing the transition from AKI to CKD.

Key words: Amino acid metabolism, Acute kidney injury, Chronic kidney disease, Transition

Junnan Guo, Hui Lin, Yilin Ren, Xi Qiao. Progress of research on the role of amino acid metabolism disturbance in the transition from AKI to CKD[J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2024, 13(05): 283-287.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhsbyjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3216.2024.05.008

https://zhsbyjdzzz.cma-cmc.com.cn/EN/Y2024/V13/I05/283

Figures/Tables 1

References 41

[1]	Perschinka F，Peer A，Joannidis M. Artificial intelligence and acute kidney injury [J]. Med Klin Intensivmed Notfmed，2024，119（3）：199-207.
[2]	Bejoy J，Qian ES，Woodard LE. Tissue culture models of AKI：from tubule cells to human kidney organoids [J]. J Am Soc Nephrol，2022，33（3）：487-501.
[3]	Horne KL，Viramontes-Hörner D，Packington R，et al. A comprehensive description of kidney disease progression after acute kidney injury from a prospective，parallel-group cohort study [J]. Kidney Int，2023，104（6）：1185-1193.
[4]	Wang Z，Zhang C. From AKI to CKD： maladaptive repair and the underlying mechanisms [J]. Int J Mol Sci，2022，23（18）：10880.
[5]	Zhao L，Hao Y，Tang S，et al. Energy metabolic reprogramming regulates programmed cell death of renal tubular epithelial cells and might serve as a new therapeutic target for acute kidney injury [J]. Front Cell Dev Biol，2023，11：1276217.
[6]	Ling ZN，Jiang YF，Ru JN，et al. Amino acid metabolism in health and disease [J]. Signal Transduct Target Ther，2023，8（1）：345.
[7]	Patschan D，Patschan S，Matyukhin I，et al. Metabolomics in acute kidney injury： the experimental perspective [J]. J Clin Med Res，2023，15（6）：283-291.
[8]	Dai X，Shen L. Advances and trends in omics technology development [J]. Front Med （Lausanne），2022，9：911861.
[9]	Lacy P. Metabolomics of sepsis-induced acute lung injury：a new approach for biomarkers [J]. Am J Physiol Lung Cell Mol Physiol，2011，300（1）： L1-L3.
[10]	林惠，乔晞. 表观遗传修饰在急性肾损伤向慢性肾脏病转变中的作用[J]. 中华肾脏病杂志，2020，36（2）：171-176.
[11]	Moreno-Gordaliza E，González-Nicolás Má，Lázaro A，et al.Untargeted metabolomics analysis of serum and urine unveils the protective effect of cilastatin on altered metabolic pathways during cisplatin-induced acute kidney injury [J]. Biochem Pharmacol，2024，227：116435.
[12]	Vašková J，Kocan L，Vaško L，et al. Glutathione-related enzymes and proteins：a review [J]. Molecules，2023，28（3）：1447.
[13]	Ferreira MJ，Rodrigues TA，Pedrosa AG，et al. Glutathione and peroxisome redox homeostasis [J]. Redox Biol，2023，67：102917.
[14]	Guo R，Duan J，Pan S，et al. The road from AKI to CKD：molecular mechanisms and therapeutic targets of ferroptosis [J].Cell Death Dis，2023，14（7）：426.
[15]	Ide S，Kobayashi Y，Ide K，et al. Ferroptotic stress promotes the accumulation of proinflammatory proximal tubular cells in maladaptive renal repair [J]. Elife，2021，10： e68603.
[16]	王小巍，张红艳，刘锐，等. 谷胱甘肽的研究进展[J]. 中国药剂学杂志（网络版），2019，17（4）：141-148.
[17]	Costa I，Barbosa DJ，Benfeito S，et al. Molecular mechanisms of ferroptosis and their involvement in brain diseases [ J].Pharmacol Ther，2023，244：108373.
[18]	Lin W，Wang C，Liu G，et al. SLC7A11/xCT in cancer：biological functions and therapeutic implications [J]. Am J Cancer Res，2020，10（10）：3106-3126.
[19]	Ding C，Ding X，Zheng J，et al. MiR-182-5p and miR-378a-3p regulate ferroptosis in I/R-induced renal injury [J]. Cell Death Dis，2020，11（10）：929.
[20]	Pei J，Pan X，Wei G，et al. Research progress of glutathione peroxidase family （GPX） in redoxidation [J]. Front Pharmacol，2023，14：1147414.
[21]	Ni L，Yuan C，Wu X. Targeting ferroptosis in acute kidney injury [J]. Cell Death Dis，2022，13（2）：182.
[22]	Caldwell RW，Rodriguez PC，Toque HA，et al. Arginase： a multifaceted enzyme important in health and disease [J]. Physiol Rev，2018，98（2）：641-665.
[23]	Maric S，Restin T，Muff JL，et al. Citrulline，biomarker of enterocyte functional mass and dietary supplement. Metabolism，transport，and current evidence for clinical use [J]. Nutrients，2021，13（8）：2794.
[24]	Hara M，Torisu K，Tomita K，et al. Arginase 2 is a mediator of ischemia-reperfusion injury in the kidney through regulation of nitrosative stress [J]. Kidney Int，2020，98（3）：673-685.
[25]	Zahedi K，Barone S，Soleimani M. Polyamine catabolism in acute kidney injury [J]. Int J Mol Sci，2019，20（19）：4790.
[26]	Zahedi K，Barone S，Brooks M，et al. Polyamine catabolism and its role in renal injury and fibrosis in mice subjected to repeated lowdose cisplatin treatment [J]. Biomedicines，2024，12（3）：640.
[27]	Bahri S，Zerrouk N，Aussel C，et al. Citrulline： from metabolism to therapeutic use [J]. Nutrition，2013，29（3）：479-484.
[28]	Rashid J，Kumar SS，Job KM，et al. Therapeutic potential of citrulline as an arginine supplement： a clinical pharmacology review [J]. Paediatr Drugs，2020，22（3）：279-293.
[29]	Wijnands KA，Castermans TM，Hommen MP，et al. Arginine and citrulline and the immune response in sepsis[J]. Nutrients，2015，7（3）：1426-1463.
[30]	Taguchi K，Sugahara S，Elias BC，et al. IL-22 is secreted by proximal tubule cells and regulates DNA damage response and cell death in acute kidney injury [J]. Kidney Int，2024，105（1）：99-114.
[31]	Tanuseputero SA，Lin MT，Yeh SL，et al. Intravenous arginine administration downregulates NLRP3 inflammasome activity and attenuates acute kidney injury in mice with polymicrobial sepsis[J]. Mediators Inflamm，2020，2020：3201635.
[32]	Zhou LY，Liu K，Yin WJ，et al. Arginase 2 mediates contrastinduced acute kidney injury via facilitating nitrosative stress in tubular cells [J]. Redox Biol，2023，67：102929.
[33]	Liang M，Wang Z，Li H，et al. l-Arginine induces antioxidant response to prevent oxidative stress via stimulation of glutathione synthesis and activation of Nrf2 pathway [J]. Food Chem Toxicol，2018，115：315-328.
[34]	Caldwell RW，Rodriguez PC，Toque HA，et al. Arginase： a multifaceted enzyme important in health and disease [J]. Physiol Rev，2018，98（2）：641-665.
[35]	赵晓庆，乔晞. 急性肾损伤向慢性肾脏病转变的机制研究进展[J]. 生命科学，2019，31（3）：279-283.
[36]	Yu J，Yu C，Bayliss G，et al. Protein arginine methyltransferases in renal development，injury，repair，and fibrosis [J]. Front Pharmacol，2023，14：1123415.
[37]	Nakayama Y，Ueda S，Yamagishi S，et al. Asymmetric dimethylarginine accumulates in the kidney during ischemia/reperfusion injury [J]. Kidney Int，2014，85（3）：570-857.
[38]	Cheng HH，Kuo CC，Yan JL，et al. Control of cyclooxygenase-2 expression and tumorigenesis by endogenous 5-methoxytryptophan[J]. Proc Natl Acad Sci USA，2012，109（33）：13231-13236.
[39]	Zheng X，Zhang A，Binnie M，et al. Kynurenine 3-monooxygenase is a critical regulator of renal ischemia-reperfusion injury [J]. Exp Mol Med，2019，51（2）：1-14.
[40]	Krupa A，Krupa MM，Pawlak K. Indoleamine 2，3 dioxygenase 1-the potential link between the innate immunity and the ischemia-reperfusion-induced acute kidney injury? [J] Int J Mol Sci，2022，23（11）：6176.
[41]	Piret SE，Guo Y，Attallah AA，et al. Krüppel-like factor 6-mediated loss of BCAA catabolism contributes to kidney injury in mice and humans [J]. Proc Natl Acad Sci USA，2021，118（23）： e2024414118.

Please choose a citation manager

Content to export